L Yao F Fang Q Wu Y Zhong L Yu 2010 No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40, 303 subjects Breast Cancer Res Treat 122 237 242 1:CAS:528:DC%2BC3cXntlKlsLY%3D 10.1007/s10549-009-0689-2 20033481
J Listgarten S Damaraju B Poulin L Cook J Dufour A Driga J Mackey D Wishart R Greiner B Zanke 2004 Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms Clin Cancer Res 10 2725 2737 1:CAS:528:DC%2BD2cXjt1CltLg%3D 10.1158/1078-0432.CCR-1115-03 15102677
TC Zimarina VN Kristensen EN Imianitov LM Bershtein 2004 Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer Mol Biol (Mosk) 38 386 393 1:STN:280:DC%2BD2czot1amtw%3D%3D 10.1023/B:MBIL.0000032200.95457.69
B Diergaarde JD Potter ER Jupe S Manjeshwar CD Shimasaki TW Pugh DC Defreese BA Gramling I Evans E White 2008 Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 17 1751 1759 1:CAS:528:DC%2BD1cXosFGhtr4%3D 10.1158/1055-9965.EPI-08-0168 18628428
Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer
18425393
BO Van Emburgh JJ Hu EA Levine LJ Mosley ND Perrier RI Freimanis GO Allen P Rubin GB Sherrill CS Shaw, et al. 2008 Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer Oncol Rep 19 1311 1321 18425393